ANNUAL REPORT - Department of Biotechnology
ANNUAL REPORT - Department of Biotechnology
ANNUAL REPORT - Department of Biotechnology
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
MEC met five times during the year to review the field<br />
trial data generated in multi-location field trials on Bt<br />
cotton. MEC also evaluated the data generated on<br />
Bt. brinjal, Bt. cabbage and Bt. cauliflower in multilocation<br />
field trials. The MEC recommended for<br />
conduct <strong>of</strong> large scale field trials and also for<br />
commercial release <strong>of</strong> Bt. cotton hybrids expressing<br />
cry1Ac gene (MON-531 event), cry1Ac (JK event No.<br />
1), cry1Ac & cry2Ab genes (MON 15985 event) and<br />
GFM cry1A gene. The department played an<br />
important role in release <strong>of</strong> 38 new Bt. cotton hybrids<br />
suitable for commercial cultivation in north, central<br />
156<br />
and south zones by GEAC.<br />
Thirteen Central Monitoring Teams were constituted<br />
by the <strong>Department</strong> to monitor multi-location field trials<br />
<strong>of</strong> Bt. cotton, Bt. brinjal, Bt. cauliflower & Bt. cabbage<br />
In r-DNA pharmaceuticals area, most <strong>of</strong> the<br />
applications filed for approvals from RCGM were by<br />
private institutions. Table-2 provides information on<br />
the products, approved by RCGM for conduct <strong>of</strong> preclinical<br />
toxicity studies and recommendations to<br />
conduct human clinical trials during the year.<br />
List <strong>of</strong> r-DNA Pharmaceuticals approved for pre-clinical and clinical studies during 2006.<br />
Sl. No. Product Institute/Industry<br />
1. rh-PEG-Interferon alpha 2b M/s. Cadila Healthcare Ltd., Ahmedabad<br />
2. rh-polysialated Interferon alpha 2b M/s. Serum Institute <strong>of</strong> India Ltd, Pune<br />
3. Modified rh-tPA-reteplase M/s. Biocon India Ltd., Bangalore<br />
4. r-reteplase M/s. Shantha Biotechnics Pvt. Ltd.,<br />
Hyderabad<br />
5. rh-polysialated erythropoietin M/s. Serum Institute <strong>of</strong> India Ltd, Pune<br />
6. Pegylated rh-erythropoietin M/s. Serum Institute <strong>of</strong> India Ltd, Pune<br />
7. rh-Erythropoietin Alpha M/s. INTAS Biopharmaceuticals Ltd.,<br />
Ahmedabad<br />
8. rh-Interferon beta 1b M/s. Cadila Healthcare Ltd., Ahmedabad<br />
9. Tetravalent vaccine (DPT+r-HB) M/s. Indian Immunologicals, Hyderabad<br />
10. r-monoclonal tetanus immunoglobulin M/s. Bharat Serum and Vaccines Ltd,<br />
Mumbai<br />
11. Recombinant Darbepoietin M/s Dr Reddy's Laboratories, Hyderabad<br />
12. Recombinant PvRII ICGEB, New Delhi<br />
DBT Annual Report 2006-07<br />
Table-2
Change language